Dr. Reddy's Laboratories Ltd — Balance Sheet (NYSE:RDY) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Total assets 3.63 B3.86 B3.92 B4.65 B5.77 B6.17 B Total liabilities 1.26 B1.35 B1.11 B1.28 B1.82 B2.12 B Total equity 2.37 B2.51 B2.81 B3.37 B3.95 B4.05 B Total liabilities & shareholders' equities 3.63 B3.86 B3.92 B4.65 B5.77 B6.17 B Total debt —————— Net debt ——————

News

Dr. Reddy's Laboratories Limited (RDY) Discusses Manufacturing Issue and Process Review for Semaglutide Transcript

India: From Generics Giant To Innovation Powerhouse?

Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push - Dr Reddy's Laboratories (NYSE:RD

Dr. Reddy's Q4 Earnings and Revenues Miss Estimates, Stock Down

Dr. Reddy's Laboratories Limited (RDY) Q4 2026 Earnings Call Transcript

AMPH vs. RDY: Which Stock Should Value Investors Buy Now?

AMRX Valuation: What 1.69x Sales Means for Investors

India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply - Novo Nordisk (NYSE:NVO)

India Is Great, But Be Careful When Everyone Agrees With The Thesis (BATS:INDA)

ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down

Zacks Industry Outlook Highlights Teva Pharmaceuticals, Sandoz and Dr. Reddy's

3 Generic Drug Stocks to Watch Despite Industry Headwinds